If you are having trouble reading this email, read the online version.
.Com Header .Com Header

Catalent Biologics Completes $14 Million Commercial Packaging Expansion

Catalent Biologics announced the completion of its $14 million expansion to increase packaging capabilities and capacity at its Bloomington, Indiana site. The completed expansion adds 15,000 square-feet of infrastructure to the biologics and sterile site, including five new integrated packaging suites, a quality control laboratory, and three high-speed automated packaging lines that have been fully qualified for late-stage clinical and commercial customers.

Learn More

Catalent’s Corporate Responsibility Report

This month, Catalent published its first Corporate Responsibility Report, bringing a new level of transparency and ambition to a wide range of environmental, social and governance topics related to Catalent’s business. Highlights in the report include Catalent’s global accreditation to ISO 14001 and OHSAS 18001; a goal to reduce its carbon emissions by 15% by 2023 by investing in energy efficiency and renewable energy; the launch of new community giving and volunteer programs; and the demonstration of its commitment to cultivating a strong, more inclusive workplace by signing the CEO Action for Diversity and Inclusion™ pledge. 


View Report

Catalent Responds to the Global Outbreak of COVID-19

As a global development and manufacturing partner that supplies medicines, clinical trial materials, and health products to millions of patients and consumers, we are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients. Many governments of the countries where we operate have recognized our work as essential, and currently, all Catalent operating facilities remain open and continuing to deliver to our customers and their patients. Read the full statement.

Learn More

Catalent Live Events

Due to the COVID-19 pandemic, many live events have either been postponed or cancelled. But you can stay current on all the latest solutions needed to advance your projects by visiting our website and tuning into these upcoming webinars and presentations.

Upcoming Expert Webinars and Virtual Events

Casss Bioassay Virtual Presentation | Supporting Bioassay Development and Execution Through Evolving Requirements and Technologies | April 27

Rob Gustines explains how Catalent’s experience in supporting customers’ bioassay development and application for decades has adapted to suit the evolving landscape, and how the company has adopted new approaches and technologies to remain current and a strong partner from development through to commercialization of vital therapeutics.

 

Webinar | Drug Manufacturing in a Time of Coronavirus | April 28

The COVID-19 pandemic has had a huge impact on so many companies R&D plans, creating new priorities overnight and forcing major shifts in many global manufacturing operations. Join us as John Carroll from Endpoints News moderates a discussion with experts from Moderna, Sanofi Pasteur, Takeda and Catalent, where they share their new realities, how they’ve adapted in the face of the pandemic, and look forward to what’s ahead.

 

Webinar | Learn how ‘Beauty Nutrition’ is emerging as a growth segment based on trends and advances in nutritional science. | April 29
Consumers around the world have started to pay more attention to how what they put in their bodies affects how they look and feel. Join this webinar and discover market trends in beauty and nutrition and discover opportunities for a range of solutions, products, and technologies.

 

Webinar | Beyond Brexit: What Now for Clinical Supply Services across Europe? | April 30
Catalent experts explore the potential challenges that sponsors face beyond the transition period, and the strategic solutions to mitigate these, in a post-Brexit Europe.

 

Webinar | Achieving Integrated Biologics Development: Challenges and How to Tackle Them | May 5
This webinar will focus on key considerations for transitioning a molecule from clinical to commercial phases, beginning with cell line development and biomanufacturing through to formulation and filling, and management of supplies for clinical studies.

 

Webinar | Managing the Changing Landscape: Building a Flexible, Challenge Resistant and Patient-Centric Clinical Supply Chain | May 6
The COVID-19 pandemic has significant potential to disrupt pharmaceutical supply chains. Register today to explore strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges.

 

CPhI Webinar Series® | Best Practices in Leveraging Phase-Appropriate Expertise and Technologies to Accelerate your Product Development to Commercialization | May 6
During this webinar, pharmaceutical scientists will present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site.

 

Webinar | Patient-Focused Drug Design: Through the Lens of Real-World | May 20

Join this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.

A Catalyst in Drug Development

Christin Hollis

Product Development Manager, Winchester, KY

Christin Hollis, PH.D. is a Product Development Manager at Catalent’s Winchester, Kentucky facility. She received a bachelor’s degree in chemical engineering and a doctorate in pharmaceutical science both from the University of Kentucky. Dr. Hollis specializes in large scale/late-stage oral dosage form drug development. Discover what drives Christin’s passion for scale-up manufacturing. Access her published works including six peer-reviewed articles, a patent, and additional executive summaries and case studies.

Catalent in the News

Catalent Receives RoSPA Silver Award for its Health and Safety Practices

 

Catalent announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for its health and safety practices, achieving a silver award for a second consecutive year. The RoSPA Awards scheme, which is the longest-running industry awards scheme in the U.K., recognizes achievement in health and safety management systems, including practices such as leadership and workforce involvement.

Read More

Top Content

BIOLOGICS

 

 CLINICAL SUPPLY / CLINICAL SERVICES

 

ORAL DRUG DELIVERY

 

CONSUMER HEALTH

 

We are hiring. Join us!

At Catalent, you will have the opportunity to thrive in a fast-paced, innovative environment where maximizing your potential isn’t just your own personal goal, it’s ours too. Our teams are rapidly growing in the greater Baltimore area, Bloomington, IN, Schorndorf, Germany and multiple other locations. Apply today!

 
Interested in working in Gene Therapy? Click here to view our openings.
Apply Today
line-divider
line-divider
Every brand has a challenge. We have a solution.
Challenge Us
or call +1 877 891 9609 to speak with one of our experts today!
Follow us on Twitter  Join us on Linkedin  Like us on Facebook  Watch our your YouTube Channel  Jobs
To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.

Catalent Pharma Solutions respects your privacy.

Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content.
© 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.